The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025,
according to a new report by Grand View Research, Inc. The emerging trend of
patient-centric services coupled with escalating incidence rates of complicated
infectious disorders is expected to upsurge the demand for portable and
accurate detection devices, thus resulting in market growth. The potential in
these devices to enable rapid detection of infectious diseases is attributive
for the estimated market.
Moreover,
revolutionizing patient care brought about by these devices is responsible for
the rising demand for decentralized testing settings. Rise in the investments
for R&D and development of new products is expected to spur progress in
this market through to 2025.
For instance,
development of a new ‘lab-on-a-disc’ technology developed by an EU project
research team aids in the diagnosis of different infectious diseases including
malaria. It enables faster diagnosis as a consequence of implementation of
point-of-care treatment. This allows precise drugs administration thus
influencing adoption rate.
Browse full report by Grand View
Research :
Further key findings from the report suggest:
·
HIV POC is estimated to account for the
largest share owing to the rising incidence of this disease
·
Advances in the bio sensing technology for
the early detection with sensitivity is expected to fuel revenue generation in
the coming years
·
Moreover, companies are engaged in
embracing a quality management approach for the introduction of novel tests for
HIV diagnosis
·
TB and drug resistant TB is anticipated to
witness lucrative demand in the coming years as a result of rise in the
incidence rate of drug resistance TB
·
Demand for the development of inexpensive,
rapid, simple, and accurate tests that are able to detect multiple biomarkers
simultaneously is expected to boost progress
·
Implementation of fully or partially
integrated nano/microscale technologies in developing DR-TB diagnostic devices
is anticipated to fuel progress in the segment
·
Clinics accounted for the largest revenue
share owing to the higher usage of rapid testing kits in clinics
·
North America dominates the space with
adequate administration support, well-established healthcare framework, and
extensive research & technology upgradation
·
Asia Pacific region is expected to showcase
the fastest growth over the forecast period due to rising incidence and
prevalence rates of infectious diseases with suitable government support
·
The major players in the sector include
Siemens Healthineers, Trivitron Healthcare, F. Hoffmann-La Roche Ltd, Alere,
Quest Diagnostics, Inc, BD & Company, Chembio Diagnostics Inc,Trinity
Biotech, Cardinal Health,Bio-Rad Labs Inc.,bioMérieux SA, Thermo Fisher
Scientific Inc, Sight Diagnostics Ltd.,Gene POC, Ortho-Clinical Diagnostics,
and OJ-Bio Ltd.
·
Companies are entering into collaborations
with academic institutions, private, and public entities to enhance their
market share
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has
segmented the point-of-care infectious disease diagnostics/testing market on
the basis of disease, end-use, and region:
Disease Outlook (Revenue, USD Million; 2014-2025)
·
HIV POC
·
Clostridium difficile POC
·
HBV POC
·
Pneumonia or Streptococcus associated
infections
·
Respiratory syncytial virus (RSV) POC
·
HPV POC
·
Influenza/Flu POC
·
HCV POC
·
MRSA POC
·
TB and drug-resistant TB POC
·
HSV (Herpes Simplex Virus) POC
·
Other infectious disease POC
End-Use Outlook (Revenue, USD Million; 2014-2025)
·
Hospitals
·
Clinics
·
Home
·
Assisted Living Healthcare Facilities
·
Laboratories
·
Others
Regional Outlook (Revenue, USD Million; 2014-2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o Japan
o China
·
Latin America
o Brazil
·
Middle East and Africa (MEA)
o South Africa
Access press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-point-of-care-infectious-disease-diagnostics-testing-market
About Grand View Research
Grand View Research,
Inc. is a U.S. based market research and consulting company, registered in the
State of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment